Tempus collaboration on pulmonary hypertension identification

United Therapeutics unveiled preliminary findings from its collaboration with Tempus, which it describes as a leader in artificial intelligence and precision medicine, laying the foundation for earlier identification of patients with pulmonary hypertension.